Published in Leukemia on March 01, 2005
A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis. Nat Cell Biol (2016) 0.90
Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma. J Proteome Res (2010) 0.90
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years. Breast Cancer Res Treat (2007) 0.83
ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia (2007) 1.64
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
Early diagnosis in colorectal cancer. Still no benefit? J R Coll Surg Edinb (1989) 1.37
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia (2013) 1.31
A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia (2009) 1.27
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia (2012) 1.27
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia (2012) 1.23
Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia (2010) 1.19
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia (2011) 1.10
Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer (2007) 1.05
Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs. Leukemia (2007) 1.04
Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet (2002) 1.01
CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood (2001) 0.99
Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity. Leukemia (2011) 0.98
Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J (2010) 0.92
Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. Leukemia (2010) 0.92
Barrett's oesophagus and colonic cancer. Lancet (1988) 0.87
Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer (2003) 0.86
The implications of cognitive psychology for computer-assisted instruction. Methods Inf Med (1989) 0.83
Tibial component fixation in knee arthroplasty. Clin Orthop Relat Res (1986) 0.82
The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia. Blood Cancer J (2011) 0.81
Micromotion of conventionally cemented all-polyethylene tibial components in total knee replacements. A roentgen stereophotogrammetric analysis of migration and inducible displacement. Arch Orthop Trauma Surg (1987) 0.81
Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant. Leukemia (2011) 0.81
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma. Leukemia (2011) 0.81
Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers. Eur J Haematol (1999) 0.81
A one-year multicenter clinical trial of pilocarpine gel. Am J Ophthalmol (1984) 0.80
Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection. Leuk Res (2001) 0.80
Early diagnosis in colorectal cancer still no benefit? Ann Chir (1989) 0.80
Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer (2000) 0.80
The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia. Leukemia (2007) 0.79
Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Lett (2008) 0.78
Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia. Leukemia (2005) 0.78
Hemodynamic changes during ventricular pacing in patients with complete heart block and aortic and mitral valvular heart disease. Am Heart J (1975) 0.77
Comparative analysis of detection systems for evaluation of PCR amplified immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol (1997) 0.76
Physical status is the principal determinant of outcome after emergency admission of patients with colorectal cancer. Ann R Coll Surg Engl (1993) 0.75
Reply to 'Male preponderance in chronic lymphocytic leukemia utilizing IGHV1-69.' When size of the sample matters. Leukemia (2007) 0.75
Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia. Leukemia (2012) 0.75
Early carcinoma of the prostate: comparison of stages A and B. J Urol (1976) 0.75
A technique for removal of filariasis of the anterior chamber. Ophthalmic Surg (1988) 0.75